176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-55.23%
Both yoy net incomes decline, with AVGO at -22.09%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
2.30%
Some D&A expansion while AVGO is negative at -1.72%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
71.70%
Some yoy growth while AVGO is negative at -78.95%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-6.63%
Negative yoy SBC while AVGO is 9.09%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-94.40%
Negative yoy working capital usage while AVGO is 145.71%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
1192.19%
AR growth well above AVGO's 279.25%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
340.24%
Inventory growth of 340.24% while AVGO is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
-38.96%
Both negative yoy AP, with AVGO at -366.67%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-131.42%
Both reduce yoy usage, with AVGO at -640.00%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
85.39%
Well above AVGO's 75.00%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-61.05%
Negative yoy CFO while AVGO is 8.02%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-37.50%
Negative yoy CapEx while AVGO is 8.77%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
16.51%
Some yoy expansion while AVGO is negative at -100.00%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
-31.87%
Both yoy lines are negative, with AVGO at -100.00%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
-768.20%
We reduce yoy other investing while AVGO is 100.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-63.17%
We reduce yoy invests while AVGO stands at 3.70%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-9.30%
We cut debt repayment yoy while AVGO is 100.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-100.00%
Both yoy lines negative, with AVGO at -53.66%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
No Data
No Data available this quarter, please select a different quarter.